A network to improve clinical trials for leukodystrophies.
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
This study is all about understanding leukodystrophies, which are genetic conditions that affect the brain's white matter, and it aims to gather important information and create helpful tools to make sure that new treatments can be tested effectively, with input from patients and their families.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10675461 on NIH RePORTER |
What this research studies
This research focuses on leukodystrophies, which are inherited disorders affecting the brain's white matter due to myelin loss. The initiative aims to enhance clinical trial readiness by gathering natural history data and developing reliable assessment tools for five specific leukodystrophies. By collaborating with advocacy groups, the project seeks to ensure that potential treatments can be effectively tested in clinical settings. Patients will be involved in providing feedback through clinical outcome assessments and patient-reported outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with specific leukodystrophies such as Adrenomyeloneuropathy, Aicard Goutieres Syndrome, Alexander Disease, Metachromatic Leukodystrophy, and Pelizaeus Merzbacher Disease.
Not a fit: Patients with leukodystrophies not included in the five targeted disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective clinical trials and ultimately better treatment options for patients with leukodystrophies.
How similar studies have performed: Other research initiatives have successfully utilized similar collaborative approaches to enhance clinical trial readiness in rare diseases.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vanderver, Adeline Lucie — Children's Hosp of Philadelphia
- Study coordinator: Vanderver, Adeline Lucie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.